You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
Moodys
McKinsey
Express Scripts

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: PALBOCICLIB

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

PALBOCICLIB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Pfizer IBRANCE palbociclib CAPSULE;ORAL 207103 NDA Pfizer Laboratories Div Pfizer Inc 0069-0187-21 21 CAPSULE in 1 BOTTLE (0069-0187-21) 2015-02-03
Pfizer IBRANCE palbociclib CAPSULE;ORAL 207103 NDA Pfizer Laboratories Div Pfizer Inc 0069-0188-21 21 CAPSULE in 1 BOTTLE (0069-0188-21) 2015-02-03
Pfizer IBRANCE palbociclib CAPSULE;ORAL 207103 NDA Pfizer Laboratories Div Pfizer Inc 0069-0189-21 21 CAPSULE in 1 BOTTLE (0069-0189-21) 2015-02-03
Pfizer IBRANCE palbociclib CAPSULE;ORAL 207103 NDA U.S. Pharmaceuticals 63539-187-11 21 CAPSULE in 1 BOTTLE (63539-187-11) 2017-05-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Medtronic
Mallinckrodt
Express Scripts